Bionomics Profit Margin

Bionomics's profit margin stands at 2468.88% as of March 2026. That compares with 53.84% in the prior-year period — up 4485.8% year over year. That is above the Healthcare sector average of 14.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bionomics reported 2468.88% in profit margin versus 53.84% a year earlier — a 4485.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Bionomics sits higher the Healthcare benchmark (14.34%) with a profit margin of 2468.88%. That is roughly 17111.0% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 2468.88% for Bionomics means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Bionomics's profit margin evolved across reporting periods, while the comparison chart places BNOX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.